Study finds that regulatory protein prevents signaling that triggers cell death
Covid-19: Early stage cancer diagnoses fell by third in first lockdown
7 May 2021New saliva oral and throat cancer diagnosis test receives FDA approval
7 May 2021Study finds that regulatory protein prevents signaling that triggers cell death
A protein implicated in neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) prevents the activation of an innate immune response that leads to cell death, Vanderbilt researchers have discovered.
